These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 21059440

  • 21. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T, Obergassel L, Lieder F, Leuner C, Strunk-Mueller C, Meyer Zu Vilsendorf D, Beer G, Kuhn H.
    Pacing Clin Electrophysiol; 2005 Apr; 28(4):295-300. PubMed ID: 15826262
    [Abstract] [Full Text] [Related]

  • 22. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M, Di Lenarda A, Proclemer A, Faganello G, Facchin D, Petz E, Sinagra G.
    Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
    [Abstract] [Full Text] [Related]

  • 23. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M, Mohammadzadeh S, Taherpour M, Faghfurian B, Fazelifar AF, Alizadeh A, Rad MA, Sadr-Ameli MA.
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [Abstract] [Full Text] [Related]

  • 24. [Interventional treatment in hypertrophic cardiomyopathy].
    Gietzen FH, Schümmelfeder J, Neuser H, Brunn J, Schumacher B, Kerber S.
    Herz; 2005 Mar; 30(2):102-10. PubMed ID: 15875098
    [Abstract] [Full Text] [Related]

  • 25. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].
    Hentati M, Ben Ameur I, Kechida Z, Charfeddine H, Hached L, Grati Z, Kammoun S.
    Tunis Med; 2003 Mar; 81 Suppl 8():675-9. PubMed ID: 14608758
    [Abstract] [Full Text] [Related]

  • 26. [Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy].
    Spirito P, Piccininno M.
    Ital Heart J Suppl; 2000 Jun; 1(6):840-1. PubMed ID: 11204022
    [No Abstract] [Full Text] [Related]

  • 27. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S.
    Circulation; 2008 Apr 15; 117(15):1918-26. PubMed ID: 18391108
    [Abstract] [Full Text] [Related]

  • 28. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.
    Can J Cardiol; 2005 Apr 15; 21(5):441-8. PubMed ID: 15861263
    [Abstract] [Full Text] [Related]

  • 29. The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy.
    O'Mahony C, Lambiase PD, Quarta G, Cardona M, Calcagnino M, Tsovolas K, Al-Shaikh S, Rahman SM, Arnous S, Jones S, McKenna W, Elliott P.
    Heart; 2012 Jan 15; 98(2):116-25. PubMed ID: 21757459
    [Abstract] [Full Text] [Related]

  • 30. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA, Rosenberg MA, Fifer MA, Palacios IF, Lowry PA, Ruskin JN, Sanborn DM, Picard MH, Vlahakes GJ, Mela T, Das S.
    Am J Cardiol; 2009 Jul 01; 104(1):128-32. PubMed ID: 19576333
    [Abstract] [Full Text] [Related]

  • 31. Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up.
    Dimitrow PP, Chojnowska L, Rudzinski T, Piotrowski W, Ziólkowska L, Wojtarowicz A, Wycisk A, Dabrowska-Kugacka A, Nowalany-Kozielska E, Sobkowicz B, Wróbel W, Aleszewicz-Baranowska J, Rynkiewicz A, Loboz-Grudzien K, Marchel M, Wysokinski A.
    Eur Heart J; 2010 Dec 01; 31(24):3084-93. PubMed ID: 20843960
    [Abstract] [Full Text] [Related]

  • 32. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.
    Francia P, Santini D, Musumeci B, Semprini L, Adduci C, Pagannone E, Proietti G, Volpe M, Autore C.
    J Cardiovasc Electrophysiol; 2014 Nov 01; 25(11):1180-7. PubMed ID: 25066044
    [Abstract] [Full Text] [Related]

  • 33. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
    McLeod CJ, Ommen SR, Ackerman MJ, Weivoda PL, Shen WK, Dearani JA, Schaff HV, Tajik AJ, Gersh BJ.
    Eur Heart J; 2007 Nov 01; 28(21):2583-8. PubMed ID: 17483110
    [Abstract] [Full Text] [Related]

  • 34. Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome?
    Rhee EK, Canter CE, Basile S, Webber SA, Naftel DC.
    J Heart Lung Transplant; 2007 May 01; 26(5):447-52. PubMed ID: 17449412
    [Abstract] [Full Text] [Related]

  • 35. Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene.
    Pasquale F, Syrris P, Kaski JP, Mogensen J, McKenna WJ, Elliott P.
    Circ Cardiovasc Genet; 2012 Feb 01; 5(1):10-7. PubMed ID: 22144547
    [Abstract] [Full Text] [Related]

  • 36. Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy.
    Woo A, Monakier D, Harris L, Hill A, Shah P, Wigle ED, Rakowski H, Rozenblyum E, Cameron DA.
    Heart; 2007 Sep 01; 93(9):1044-5. PubMed ID: 17699173
    [Abstract] [Full Text] [Related]

  • 37. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, Crosson J, Spevak PJ, Berger RD, Halperin HR, Calkins H.
    J Am Coll Cardiol; 2004 May 19; 43(10):1843-52. PubMed ID: 15145110
    [Abstract] [Full Text] [Related]

  • 38. Ventricular fibrillation during sleep in an adolescent with hypertrophic cardiomyopathy: the difficulty of risk stratification and the power of the cardioverter-defibrillator.
    Boriani G, Biffi M, Rapezzi C, Coccolo F, Branzi A, Spirito P.
    Int J Cardiol; 2004 Oct 19; 97(1):143-4. PubMed ID: 15336824
    [No Abstract] [Full Text] [Related]

  • 39. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
    Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM.
    Ital Heart J; 2005 Mar 19; 6(3):272-80. PubMed ID: 15875520
    [Abstract] [Full Text] [Related]

  • 40. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G, Elliott PM, Pacileo G, Sarubbi B, Thaman R, Calabrò P, Vergara P, Iacomino M, Russo MG, Calabrò R.
    J Cardiovasc Med (Hagerstown); 2006 Sep 19; 7(9):711-3. PubMed ID: 16932087
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.